Pomara, Nunzio http://orcid.org/0000-0002-8075-4253
Bruno, Davide
Plaska, Chelsea Reichert http://orcid.org/0000-0001-9662-6179
Ramos-Cejudo, Jaime
Osorio, Ricardo S.
Pillai, Anilkumar http://orcid.org/0000-0002-1952-8556
Imbimbo, Bruno P.
Zetterberg, Henrik http://orcid.org/0000-0003-3930-4354
Blennow, Kaj http://orcid.org/0000-0002-1890-4193
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH-080405)
Article History
Received: 6 May 2022
Revised: 14 July 2022
Accepted: 19 July 2022
First Online: 28 July 2022
Competing interests
: H.Z. has served at scientific advisory boards for Alector, Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies and CogRx, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. All unrelated to the work presented in this paper. R.S.O. is a member of ‘The Alliance for Sleep’ which is sponsored by Idorsia U.S.